Ever Supreme Bio Technology Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Ever Supreme Bio Technology has a total shareholder equity of NT$1.5B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.8B and NT$261.4M respectively. Ever Supreme Bio Technology's EBIT is NT$402.3M making its interest coverage ratio -43.5. It has cash and short-term investments of NT$649.8M.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
NT$0
Schuld
| Rente dekkingsratio | -43.5x |
| Contant | NT$649.78m |
| Aandelen | NT$1.54b |
| Totaal verplichtingen | NT$261.37m |
| Totaal activa | NT$1.80b |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 6712's short term assets (NT$860.6M) exceed its short term liabilities (NT$235.7M).
Langlopende schulden: 6712's short term assets (NT$860.6M) exceed its long term liabilities (NT$25.7M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 6712 is debt free.
Schuld verminderen: 6712 had no debt 5 years ago.
Schuldendekking: 6712 has no debt, therefore it does not need to be covered by operating cash flow.
Rentedekking: 6712 has no debt, therefore coverage of interest payments is not a concern.